Coronavirus (COVID-19) resources

Tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis

To assess the benefits and harms of TNF inhibitors in comparison with placebo and other treatment strategies in adult patients affected by psoriatic arthritis.

This is a protocol.

You may also be interested in:

Health topics:

Rheumatology > Spondylo-arthropathy

Published:

14 May 2020

Authors:

Cagnotto G, Compagno M, Scire CAlberto, Bruschettini M

Primary Review Group:

Musculoskeletal Group

See the full Review on

the Cochrane Library

Print
PDF
Citation
Cagnotto G, Compagno M, Scire CAlberto, Bruschettini M. Tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis (Protocol). Cochrane Database of Systematic Reviews 2020, Issue 5. Art. No.: CD013614. DOI: 10.1002/14651858.CD013614.